Renal Dose Adjustment
Hepatic Dose Adjustment
Priftin interacts with :
Pregnancy Category:C
Breastfeeding: Safety unknown. According to the AAP, women with tuberculosis who have been treated for > 2 wks and who are not considered contagious may breastfeed. This drug is compatible and considered safe with breastfeeding based upon data from AAP Policy Guidelines (available at http://aappolicy.aappublications.org/cgi/content/full/pediatrics;108/3/776 last accessed 30 November 2009). Manufacturer recommends discontinuation of breastfeeding or discontinuation of drug taking into account the importance of the drug to the mother.
US Trade Name(s)
US Availability
Priftin
Canadian Trade Name(s)
Canadian Availability
UK Trade Name(s)
UK Availability
Australian Trade Name(s)
Australian Availability
Antimicrobials
Antituberculosis AgentsRifamycin Derivatives
Infectious Disease
Antituberculosis AgentsRifamycin Derivatives
Drug Name: Priftin 150 MG Oral Tablet
Ingredient(s): Rifapentine
Imprint: Priftin;150
Color(s): Pink
Shape: Round
Size (mm): 10.00
Score: 1
Inactive Ingredient(s): calcium stearate / fd&c blue no. 2 / aluminum oxide / hydroxypropyl cellulose / hypromellose / cellulose, microcrystalline / polyethylene glycol / propylene glycol / sodium ascorbate / sodium lauryl sulfate / ferric oxide red / titanium dioxide
Drug Label Author:
sanofi-aventis U.S. LLC
DEA Schedule:
Non-Scheduled
